Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33). [electronic resource]
Producer: 20120424Description: 1789-95 p. digitalISSN:- 1433-7339
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Drug Administration Schedule
- Epirubicin -- administration & dosage
- Female
- Fever -- prevention & control
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Leukopenia -- chemically induced
- Middle Aged
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Polyethylene Glycols
- Prospective Studies
- Recombinant Proteins -- administration & dosage
- Time Factors
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.